Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Autoimmune Disorders

Free Subscription 09.06.2025 1 Ann Neurol 3 BMC Neurol 1 Brain 3 Curr Opin Immunol 1 Diabetes 8 Intern Med 1 J Nephrol 5 J Neurol 3 Mult Scler 4 Neurology 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. SABATINO JJ JR, Cree BAC, Hauser SL
   New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond.
   Ann Neurol. 2025 Jun 6. doi: 10.1002/ana.27270.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. YALCIN GY, Tulek Z, Kurtuncu M
   Effect of a nurse-led online patient support program on fatigue, sleep and quality of life in patients with multiple sclerosis: a quasi-experimental study.
   BMC Neurol. 2025;25:238.
   PubMed         Abstract available
   
   
3. AZIMIRAD M, Hamtaeigashti S, Raeisi H, Looha MA, et al
   Prevalence of epsilon toxin-producing Clostridium perfringens isolates among patients with multiple sclerosis and neuromyelitis optica spectrum disorder in Iran.
   BMC Neurol. 2025;25:234.
   PubMed         Abstract available
   
   
4. KOUCHAKI E, Bayat S, Asgarian FS
   Sleep disorders in patients with multiple sclerosis.
   BMC Neurol. 2025;25:237.
   PubMed         Abstract available
   
   

   
   Brain

5. MAUDES E, Planaguma J, Marmolejo L, Radosevic M, et al
   Neuro-immunobiology and treatment assessment in a mouse model of anti-NMDAR encephalitis.
   Brain. 2025;148:2023-2037.
   PubMed         Abstract available
   
   

   
   Curr Opin Immunol

6. MAUDES E, Planaguma J, Weber MS, Dalmau J, et al
   Animal models of autoimmune encephalitis.
   Curr Opin Immunol. 2025;95:102579.
   PubMed         Abstract available
   
   
7. CHEN J, Wang X
   Epigenetic regulation of B cell response in autoimmune diseases.
   Curr Opin Immunol. 2025;95:102582.
   PubMed         Abstract available
   
   
8. LE PANSE R
   Is there a path to cure myasthenia gravis?
   Curr Opin Immunol. 2025;95:102577.
   PubMed         Abstract available
   
   

   
   Diabetes

9. LU T, Manousaki D, Sun L, Paterson AD, et al
   Integrative proteogenomic analyses provide novel interpretations of type 1 diabetes risk loci through circulating proteins.
   Diabetes. 2025 Jan 6:db240380. doi: 10.2337/db24-0380.
   PubMed         Abstract available
   
   

   
   Intern Med

10. UZAWA A, Suzuki S, Kuwabara S, Yasuda M, et al
    Corticosteroid-induced Cushingoid Appearance in Myasthenia Gravis.
    Intern Med. 2025 Jun 5. doi: 10.2169/internalmedicine.5678.
    PubMed         Abstract available
    
    
11. YASUDA T, Hagino N
    Hemorrhagic Pneumonia due to Stenotrophomonas maltophilia in a Patient with Systemic Lupus Erythematosus-associated Thrombotic Microangiopathy under Immunosuppressive Therapy.
    Intern Med. 2025 Jun 5. doi: 10.2169/internalmedicine.5681.
    PubMed         Abstract available
    
    
12. FINSTERER J
    SARS-CoV-2 Infection in Sjogren Syndrome can be Complicated by Myelitis and Guillain-Barre Syndrome.
    Intern Med. 2025 Jun 5. doi: 10.2169/internalmedicine.5784.
    PubMed        
    
    
13. FUNAKOSHI T, Yamada M, Ikeda K, Yokokawa K, et al
    Response to SARS-CoV-2 Infection in Sjogren Syndrome can be Complicated by Myelitis and Guillain-Barre Syndrome.
    Intern Med. 2025 Jun 5. doi: 10.2169/internalmedicine.5826.
    PubMed        
    
    
14. YAMANO A, Ozawa T, Endo T, Koike M, et al
    Bortezomib Led to Remission of Immune Thrombocytopenic Purpura in a Patient with Smoldering Multiple Myeloma.
    Intern Med. 2025;64:1733-1736.
    PubMed         Abstract available
    
    
15. YAMAMOTO M, Dembo T, Sawada K, Hashimoto B, et al
    Vessel Wall Magnetic Resonance Imaging Showing Intravascular Large B-cell Lymphoma Infiltration: Association with Pathological Findings.
    Intern Med. 2025;64:1742-1745.
    PubMed         Abstract available
    
    
16. NISHIMURA N, Kawano S, Tamae A, Yoshizawa S, et al
    Garcin Syndrome in a Patient with Hypertrophic Pachymeningitis Following Otitis Media with Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis (OMAAV).
    Intern Med. 2025;64:1756-1760.
    PubMed         Abstract available
    
    
17. SHIGEMATSU T, Yamaguchi Y, Watanabe T, Tsujimoto K, et al
    New-onset Fulminant Type 1 Diabetes Following COVID-19 Vaccination.
    Intern Med. 2025;64:1691-1695.
    PubMed         Abstract available
    
    

    
    J Nephrol

18. ISHIGAKI S, Takei H, Hiramoto K, Kaneko Y, et al
    Plasma cell-rich interstitial nephritis without glomerulonephritis in granulomatosis with polyangiitis.
    J Nephrol. 2025 May 30. doi: 10.1007/s40620-025-02318.
    PubMed        
    
    

    
    J Neurol

19. CHEN H
    A disproportionality analysis of nervous system adverse events associated with disease-modifying therapies in multiple sclerosis: insights from the FDA adverse event reporting system (FAERS).
    J Neurol. 2025;272:445.
    PubMed         Abstract available
    
    
20. GERAN R, Steiner OL, Krasivskaya E, Hannemann U, et al
    Inverse relation between serum neurofilament light chain and cognitive function in chronic inflammatory demyelinating polyneuropathy.
    J Neurol. 2025;272:439.
    PubMed         Abstract available
    
    
21. MACCORA S, Vinciguerra C, Messina C, Bevilacqua L, et al
    Double seronegative myasthenia gravis and mimics: a retrospective cross-sectional study by two tertiary centers in the Southern Italy.
    J Neurol. 2025;272:433.
    PubMed         Abstract available
    
    
22. NEYAL N, Krey KJ, Morrison HA, Nathoo N, et al
    From checkboxes to emojis: a novel approach to patient-reported outcomes in multiple sclerosis.
    J Neurol. 2025;272:434.
    PubMed         Abstract available
    
    
23. MALUCCHI S, Bava CI, Valentino P, Martire S, et al
    Correction: In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting.
    J Neurol. 2025;272:444.
    PubMed        
    
    

    
    Mult Scler

24. NOVAKOVA L, Rosenstein I, Axelsson M, Schoonheim MM, et al
    Plateau of practice effects and noise with repeat SDMT testing and in multiple sclerosis.
    Mult Scler. 2025 May 31:13524585251344794. doi: 10.1177/13524585251344794.
    PubMed         Abstract available
    
    
25. NEYAL N, Nathoo N, Cathcart-Rake EJ, Kantarci OH, et al
    Gender-affirming interventions and prognosis in multiple sclerosis.
    Mult Scler. 2025 Jun 3:13524585251341174. doi: 10.1177/13524585251341174.
    PubMed         Abstract available
    
    
26. MOCCIA M
    Clinical commentary to gender-affirming interventions and prognosis in multiple sclerosis.
    Mult Scler. 2025 Jun 3:13524585251341177. doi: 10.1177/13524585251341177.
    PubMed        
    
    

    
    Neurology

27. JIA A, Price TR, Rosner J, Broderick C, et al
    Journal Club: Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide Retrospective Cohort Study.
    Neurology. 2025;105:e213663.
    PubMed         Abstract available
    
    
28. GOYNE C, Fair AE, Yilmaz D, Race J, et al
    Epigenetic Aging in Pediatric-Onset Multiple Sclerosis.
    Neurology. 2025;104:e213673.
    PubMed         Abstract available
    
    
29. JUL JARBAEK NIELSEN J, Levison L, Andersen H
    Mortality in Myasthenia Gravis in Denmark From 1985 to 2020: A Population-Based Cohort Study.
    Neurology. 2025;104:e213745.
    PubMed         Abstract available
    
    
30. YEH EA
    Accelerated Aging in Children With Multiple Sclerosis: Can We Stop the Clock?
    Neurology. 2025;104:e213840.
    PubMed        
    
    

    
    PLoS One

31. JARAB AS, Al-Qerem WA, Alqudah S, Alzoubi KH, et al
    Insulin-self administration among individuals with diabetes: Implications for improved practices.
    PLoS One. 2025;20:e0324846.
    PubMed         Abstract available
    
    
32. WULLER S, Singer NG, Lewis C, Karlson EW, et al
    Severity of acute SARS-CoV-2 infection and risk of new-onset autoimmune disease: A RECOVER initiative study in nationwide U.S. cohorts.
    PLoS One. 2025;20:e0324513.
    PubMed         Abstract available
    
    
33. ANGENETE OW, Haustreis J, Aune LK, Lundestad A, et al
    Children as controls in research; The voice of the volunteer.
    PLoS One. 2025;20:e0325069.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.